Medical Innovation Xccelerator™ (MIX)
Accelerating drug development using advanced tissue models
The development of new drugs is an expensive, lengthy, and risky process. Occasionally, resources are wasted on drug candidates that eventually turn out to have an undesirable kidney pharmacology and/or toxicology. We therefore offer contract research services based on whole kidney perfusion and precision-cut kidney slices to help biotech and pharma companies select the most promising drug candidates during early stages of development.